 and Levemir® (insulin detemir) significantly reduce severe hypoglycaemia<br />
<b>Deprecated</b>: urlencode(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Data from the independent investigator-initiated HypoAna study published in The Lancet Diabetes & Endocrinology, shows that Novo Nordisk’s short-acting and long-acting modern insulin analogues NovoRapid® (insulin aspart) and Levemir® (insulin detemir) significantly reduce severe hypoglycaemia in people with type 1 diabetes compared to human insulin (regular/NPH).
Read more